Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
» Chapel Hill drug developer Cempra sees stock bounce on pneumonia trial
Chapel Hill drug developer Cempra sees stock bounce on pneumonia trial
Chapel Hill drug developer Cempra sees stock bounce on pneumonia trial
Submitted by
admin
on July 7, 2015 - 10:30am
Source:
Bizjournals.com
News Tags:
Cempra
community acquired bacterial pneumonia
Solithromycin
Headline:
Chapel Hill drug developer Cempra sees stock bounce on pneumonia trial
Do Not Allow Advertisers to Use My Personal information
